These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 28964258)
1. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia. Chaorattanakawee S; Lon C; Chann S; Thay KH; Kong N; You Y; Sundrakes S; Thamnurak C; Chattrakarn S; Praditpol C; Yingyuen K; Wojnarski M; Huy R; Spring MD; Walsh DS; Patel JC; Lin J; Juliano JJ; Lanteri CA; Saunders DL Malar J; 2017 Sep; 16(1):392. PubMed ID: 28964258 [TBL] [Abstract][Full Text] [Related]
2. Ex vivo susceptibilities of Plasmodium vivax isolates from the China-Myanmar border to antimalarial drugs and association with polymorphisms in Pvmdr1 and Pvcrt-o genes. Li J; Zhang J; Li Q; Hu Y; Ruan Y; Tao Z; Xia H; Qiao J; Meng L; Zeng W; Li C; He X; Zhao L; Siddiqui FA; Miao J; Yang Z; Fang Q; Cui L PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008255. PubMed ID: 32530913 [TBL] [Abstract][Full Text] [Related]
3. Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia. Roesch C; Mairet-Khedim M; Kim S; Lek D; Popovici J; Witkowski B J Antimicrob Chemother; 2020 Jul; 75(7):1766-1771. PubMed ID: 32211790 [TBL] [Abstract][Full Text] [Related]
4. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil. Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU Malar J; 2014 Feb; 13():73. PubMed ID: 24581308 [TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand. Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia. Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan. Khattak AA; Venkatesan M; Khatoon L; Ouattara A; Kenefic LJ; Nadeem MF; Nighat F; Malik SA; Plowe CV Malar J; 2013 Sep; 12():310. PubMed ID: 24007534 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia. Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252 [TBL] [Abstract][Full Text] [Related]
10. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance. Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942 [TBL] [Abstract][Full Text] [Related]
11. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Russell B; Chalfein F; Prasetyorini B; Kenangalem E; Piera K; Suwanarusk R; Brockman A; Prayoga P; Sugiarto P; Cheng Q; Tjitra E; Anstey NM; Price RN Antimicrob Agents Chemother; 2008 Mar; 52(3):1040-5. PubMed ID: 18180357 [TBL] [Abstract][Full Text] [Related]
12. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia. Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA Malar J; 2013 Jul; 12():239. PubMed ID: 23849006 [TBL] [Abstract][Full Text] [Related]
13. Chloroquine efficacy studies confirm drug susceptibility of Plasmodium vivax in Chennai, India. Shalini S; Chaudhuri S; Sutton PL; Mishra N; Srivastava N; David JK; Ravindran KJ; Carlton JM; Eapen A Malar J; 2014 Mar; 13():129. PubMed ID: 24685286 [TBL] [Abstract][Full Text] [Related]
14. Molecular Surveillance and Zeng W; Zhao H; Zhao W; Yang Q; Li X; Li X; Duan M; Wang X; Li C; Xiang Z; Chen X; Cui L; Yang Z Front Cell Infect Microbiol; 2021; 11():738075. PubMed ID: 34790586 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay. Tyner SD; Lon C; Se Y; Bethell D; Socheat D; Noedl H; Sea D; Satimai W; Schaecher K; Rutvisuttinunt W; Fukuda MM; Chaorattanakawee S; Yingyuen K; Sundrakes S; Chaichana P; Saingam P; Buathong N; Sriwichai S; Chann S; Timmermans A; Saunders DL; Walsh DS Malar J; 2012 Jun; 11():198. PubMed ID: 22694953 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries. Lu F; Lim CS; Nam DH; Kim K; Lin K; Kim TS; Lee HW; Chen JH; Wang Y; Sattabongkot J; Han ET Acta Trop; 2011 Feb; 117(2):69-75. PubMed ID: 20933490 [TBL] [Abstract][Full Text] [Related]
17. Assessment of copy number variation in genes related to drug resistance in Plasmodium vivax and Plasmodium falciparum isolates from the Brazilian Amazon and a systematic review of the literature. Costa GL; Amaral LC; Fontes CJF; Carvalho LH; de Brito CFA; de Sousa TN Malar J; 2017 Apr; 16(1):152. PubMed ID: 28420389 [TBL] [Abstract][Full Text] [Related]
18. Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana. Faway E; Musset L; Pelleau S; Volney B; Casteras J; Caro V; Menard D; Briolant S; Legrand E Malar J; 2016 Nov; 15(1):540. PubMed ID: 27825387 [TBL] [Abstract][Full Text] [Related]
19. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility. Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783 [TBL] [Abstract][Full Text] [Related]
20. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]